サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1477962

脳神経外科手術市場：地域別（北米、欧州、アジア太平洋、ラテンアメリカ、中東アフリカ）：世界の産業分析、規模、シェア、成長、動向、2024-2032年予測

Neurosurgery Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032
出版日: | 発行: Persistence Market Research | ページ情報: 英文 300 Pages | 納期: 2～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.13円
脳神経外科手術市場：地域別（北米、欧州、アジア太平洋、ラテンアメリカ、中東アフリカ）：世界の産業分析、規模、シェア、成長、動向、2024-2032年予測
出版日: 2024年05月02日
発行: Persistence Market Research
ページ情報: 英文 300 Pages
納期: 2～5営業日
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Research社は、脳神経外科手術市場を徹底的に分析し、その世界の展望を詳述した包括的なレポートを提供しています。この詳細な出版物は、市場力学、動向、機会、課題に関する貴重な洞察を提供し、その構造の包括的な概要を提供します。排他的なデータと統計に裏打ちされた、脳神経外科手術市場2024年から2032年にスパンの予想成長軌道を予測します。

脳神経外科手術市場の世界売上高は、2024年末までに43億7,000万米ドルに達し、CAGR4.5％で安定的に成長すると予測されています。この軌跡により、2032年末には市場は約79億米ドルにまで成長すると予測されています。

主な洞察

  • 脳神経外科手術市場規模（2024年）：43億7,000万米ドル
  • 予測市場価値（2032年）：79億米ドル
  • 世界市場成長率（CAGR 2024-2032）：4.5%

脳神経外科手術市場：調査範囲

脳神経外科手術には、脳、脊髄、末梢神経を含む神経系に影響を及ぼす疾患の治療を目的とした外科手術が含まれます。脳神経外科手術市場には、神経疾患の診断と治療に使用される幅広い手術手技、機器、技術が含まれます。主なセグメントには、神経刺激装置、神経内視鏡システム、神経外科ナビゲーションシステム、神経インターベンション装置などがあります。

市場成長の原動力となっているのは、神経疾患の有病率の増加、手術手技や技術の進歩、低侵襲手術に対する需要の高まりといった要因です。さらに、医療費の増加、老人人口の拡大、新興国における医療インフラの改善なども市場拡大に寄与しています。

市場成長の促進要因：

脳卒中、てんかん、パーキンソン病、脳腫瘍などの神経疾患の有病率の増加

正確な診断と治療計画を可能にする神経画像技術の進歩

低侵襲脳神経外科手術手術の採用が増加し、患者の不快感や回復に要する時間が減少

慢性疼痛、運動障害、精神疾患の管理を目的とした神経刺激装置の需要の高まり

ヘルスケアインフラの拡大と発展途上地域における神経外科専門センターの利用可能性

市場の抑制要因：

神経外科手術や機器にかかる費用が高く、低所得地域でのアクセスが制限されています。

機器承認のための規制要件が厳しく、市場投入までの期間が延び、開発コストが高くなります。

熟練した神経外科医や神経科医が不足しており、特に農村部や医療が行き届いていない地域でその傾向が強いです。

特定の神経外科技術や機器の安全性や有効性に関する懸念が、患者やヘルスケア提供者の躊躇につながっています。

市場機会：

精神疾患、運動障害、慢性疼痛疾患の治療における神経外科の新たな応用。

ニューロイメージングと手術ナビゲーションシステムにおける人工知能（AI）と機械学習（ML）技術の統合

革新的な神経外科ソリューションを開発するための、業界利害関係者、研究機関、ヘルスケアプロバイダー間の協力。

遠隔医療および遠隔モニタリングサービスの拡大により、遠隔地や十分なサービスを受けていない地域における神経外科専門医へのアクセスが向上

本レポートで扱う主な質問

  • 世界の脳神経外科手術市場の成長を促す主な要因は何か？
  • 最も需要が高く、採用率が高いのはどの神経外科手術技術および機器か？
  • 技術の進歩は、脳神経外科手術市場の競合情勢をどのように変えているのか？
  • 脳神経外科手術市場に貢献している主要企業はどこか、また市場の関連性を維持するためにどのような戦略を採用しているのか？
  • 世界の脳神経外科手術市場における新たな動向と将来展望は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/分類
  • 市場の定義/範囲/制限
  • 含まれるものと含まれないも

第3章 主要な市場動向

  • 市場に影響を与える主な動向
  • 製品イノベーション/開発動向

第4章 重要成功要因

  • 主要な疾病疫学
  • 製品の採用/使用状況分析
  • 製品のUSP/特徴
  • メーカー別の主なプロモーション戦略
  • ポーターの分析
  • PESTLE分析
  • バリューチェーン分析

第5章 市場背景

  • マクロ経済要因
  • 予測要因-関連性と影響
  • 市場力学

第6章 COVID-19危機分析

  • COVID-19と影響分析
    • 製品別収益
    • エンドユーザー別収益
    • 国別収益
  • 2024年の市場シナリオ

第7章 世界の脳神経外科手術市場の需要（金額および規模）

  • 過去の市場（金額）分析、2019-2023年
  • 現在および将来の市場（金額）予測、2024～2032年

第8章 世界の脳神経外科手術市場分析：製品別

  • イントロダクション/主な調査結果
  • 過去の市場規模（金額）分析、2019-2023年
  • 現在および将来の市場規模（金額）分析と予測、2024-2032年
    • 神経介入デバイス
      • 神経血管塞栓デバイス
        • 塞栓コイル
        • 液体塞栓システム
        • 血流転換ステント
        • 動脈瘤クリップ
      • 神経血管コイル補助装置
        • コイルアシストステント
        • コイルアシストバルーン
      • 神経血管血栓除去装置
        • ステント回収装置
        • アスピレーションレトリーバー
      • マイクロガイドワイヤー
      • マイクロカテーテル
      • サポートカテーテル
      • 頭蓋内ステント
    • 神経内視鏡
      • フレキシブル神経内視鏡
      • 硬性神経内視鏡
    • 脳神経外科手術用ドリル
      • 空気圧式脳神経外科手術ドリル
      • 電気脳神経外科手術用ドリル
    • 放射線手術システム
      • 直線加速放射線手術システム
      • ガンマナイフ放射線治療システム
    • 硬膜代替品
      • 生物学的硬膜代替物
      • 合成硬膜代替品
    • 脳神経外科手術用アブレーション装置
      • MRI誘導集束超音波システム
      • MRI誘導レーザー治療システム
      • MRI誘導RFアブレーションシステム
    • 脳神経外科手術用器具
      • 組織リトラクター
      • 鉗子
      • ヘッドフレーム
      • 頸部プレーティングシステム
      • 穿孔器
  • 製品別市場魅力度分析

第9章 世界の脳神経外科手術市場分析：エンドユーザー別

  • イントロダクション/主な調査結果
  • 過去の市場規模（金額）分析、2019-2023年
  • 現在および将来の市場規模（金額）分析と予測、2024-2032年
    • 病院
    • 外来手術センター
    • 専門神経学研究所
  • エンドユーザー別市場魅力度分析

第10章 世界の脳神経外科手術市場分析：地域別

  • イントロダクション
  • 過去の市場規模（金額）分析、2019-2023年
  • 現在および将来の市場規模（金額）分析と予測、2024-2032年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東およびアフリカ（MEA）
  • 地域別市場魅力度分析

第11章 北米の脳神経外科手術市場分析

第12章 ラテンアメリカの脳神経外科手術市場分析

第13章 欧州の脳神経外科手術市場分析

第14章 南アジアおよび太平洋地域の脳神経外科手術市場分析

第15章 東アジアの脳神経外科手術市場分析

第16章 オセアニアの脳神経外科手術市場分析

第17章 中東およびアフリカの脳神経外科手術市場分析

第18章 市場構造分析

  • 企業階層別市場分析
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第19章 競合分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 競合の詳細
    • Stryker Corp.
    • B. Braun Melsungen AG
    • Medtronic plc
    • DePuy Synthes
    • Boston Scientific
    • Terumo Corporation
    • KARL STORZ GmbH &Co KG
    • Integra LifeSciences
    • Penumbra Inc
    • Adeor Medical AG
    • Elekta
    • Clarus Medical
    • MACHIDA ENDOSCOPE CO., LTD.

第20章 使用される前提条件と頭字語

第21章 調査手法

目次
Product Code: PMRREP4790

Persistence Market Research has conducted a thorough analysis of the Neurosurgery Market, providing a comprehensive report detailing its global landscape. This in-depth publication offers valuable insights into the market's dynamics, trends, opportunities, and challenges, providing a comprehensive overview of its structure. Backed by exclusive data and statistics, the research predicts the anticipated growth trajectory of the Neurosurgery Market spanning from 2024 to 2032.

The neurosurgery market's global revenue stood at US$ 4.37 billion by the close of 2024, projected to grow steadily with a compound annual growth rate (CAGR) of 4.5%. This trajectory is expected to propel the market to approximately US$ 7.9 billion by the conclusion of 2032.

Key Insights:

  • Neurosurgery Market Size (2024): US$ 4.37 billion
  • Projected Market Value (2032): US$ 7.9 billion
  • Global Market Growth Rate (CAGR 2024-2032): 4.5%

Neurosurgery Market - Report Scope:

Neurosurgery involves surgical procedures aimed at treating conditions affecting the nervous system, including the brain, spinal cord, and peripheral nerves. The neurosurgery market encompasses a wide range of surgical techniques, devices, and technologies used in the diagnosis and treatment of neurological disorders. Key segments include neurostimulation devices, neuroendoscopy systems, neurosurgical navigation systems, and neurointerventional devices.

Market growth is driven by factors such as the increasing prevalence of neurological disorders, advancements in surgical techniques and technologies, and growing demand for minimally invasive procedures. Additionally, rising healthcare expenditures, expanding geriatric population, and improving healthcare infrastructure in emerging economies contribute to market expansion.

Market Growth Drivers:

Increasing prevalence of neurological disorders such as stroke, epilepsy, Parkinson's disease, and brain tumors

Advancements in neuroimaging techniques, enabling accurate diagnosis and treatment planning

Growing adoption of minimally invasive neurosurgical procedures, reducing patient discomfort and recovery times

Rising demand for neurostimulation devices for the management of chronic pain, movement disorders, and psychiatric conditions

Expansion of healthcare infrastructure and the availability of specialized neurosurgical centers in developing regions

Market Restraints:

High cost associated with neurosurgical procedures and devices, limiting access in low-income regions

Stringent regulatory requirements for device approval, leading to extended time-to-market and higher development costs

Lack of skilled neurosurgeons and neurologists, particularly in rural and underserved areas

Concerns regarding the safety and efficacy of certain neurosurgical techniques and devices, leading to hesitancy among patients and healthcare providers

Market Opportunities:

Emerging applications of neurosurgery in the treatment of psychiatric disorders, movement disorders, and chronic pain conditions

Integration of artificial intelligence (AI) and machine learning (ML) technologies in neuroimaging and surgical navigation systems

Collaboration between industry stakeholders, research institutions, and healthcare providers to develop innovative neurosurgical solutions

Expansion of telemedicine and remote monitoring services, improving access to neurosurgical expertise in remote and underserved areas

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the neurosurgery market globally?
  • Which neurosurgical techniques and devices are experiencing the highest demand and adoption rates?
  • How are technological advancements reshaping the competitive landscape of the neurosurgery market?
  • Who are the key players contributing to the neurosurgery market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global neurosurgery market?

Competitive Intelligence and Business Strategy:

Leading players in the global neurosurgery market, including Medtronic plc, Stryker Corporation, Johnson & Johnson, and Integra LifeSciences Holdings Corporation, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in research and development to develop advanced neurosurgical devices and technologies, catering to the evolving needs of patients and healthcare providers.

Collaborations with neurology and neurosurgery centers, academic institutions, and government agencies facilitate market access and technology adoption. Moreover, emphasis on physician training, patient education, and clinical research promotes evidence-based practice and improves patient outcomes in the rapidly evolving field of neurosurgery.

Key Companies Profiled

  • B. Braun Melsungen AG
  • Medtronic plc
  • DePuy Synthes
  • Boston Scientific
  • Stryker Corp.
  • Terumo Corporation
  • KARL STORZ GmbH & Co KG
  • Integra LifeSciences
  • Penumbra Inc
  • Adeor Medical AG
  • Elekta
  • Clarus Medical
  • MACHIDA ENDOSCOPE CO., LTD.

Key Segments Covered in Neurosurgery Industry Research

Neurosurgery Market by Product:

  • Neuro Interventional Devices
  • Neuroendoscopes
  • Neurosurgical Drills
  • Radiosurgery Systems
  • Dura Substitutes
  • Neurosurgery Instruments

Neurosurgery Market by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Neurological Institutes

Neurosurgery Market by Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply-Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions & Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Key Disease Epidemiology
  • 4.2. Product Adoption / Usage Analysis
  • 4.3. Product USPs / Features
  • 4.4. Key Promotional Strategies, By Manufacturers
  • 4.5. Porter's Analysis
  • 4.6. PESTLE Analysis
  • 4.7. Value Chain Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global Healthcare Market GDP and Growth Outlook
    • 5.1.2. Global Assistive Devices Market Overview
    • 5.1.3. Medical Device Industry Overview
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. GDP Growth Forecast
    • 5.2.2. Ageing Population
    • 5.2.3. Growing Prevalence of Neurologic Diseases
    • 5.2.4. Growing Healthcare Expenditure
    • 5.2.5. Shift Towards Minimally Invasive Procedures
    • 5.2.6. Growing Research Efforts
    • 5.2.7. Cost Impact
    • 5.2.8. Entries Of New Start-Up Companies In The Market
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. Revenue By Product
    • 6.1.2. Revenue By End User
    • 6.1.3. Revenue by Country
  • 6.2. 2024 Market Scenario

7. Global Neurosurgery Market Demand (in Value or Size (US$ Mn) Analysis 2019-2023 and Forecast, 2024-2032

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2032
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032, By Product

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Product, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2024-2032
    • 8.3.1. Neuro Interventional Devices
      • 8.3.1.1. Neurovascular Embolization Devices
        • 8.3.1.1.1. Embolization Coils
        • 8.3.1.1.2. Liquid Embolic Systems
        • 8.3.1.1.3. Flow Diversion Stents
        • 8.3.1.1.4. Aneurysm Clips
      • 8.3.1.2. Neurovascular Coiling Assist Devices
        • 8.3.1.2.1. Coiling Assist Stents
        • 8.3.1.2.2. Coiling Assist Balloons
      • 8.3.1.3. Neurovascular Thrombectomy Devices
        • 8.3.1.3.1. Stent Retrievers
        • 8.3.1.3.2. Aspiration Retrievers
      • 8.3.1.4. Microguidewires
      • 8.3.1.5. Microcatheters
      • 8.3.1.6. Support Catheters
      • 8.3.1.7. Intracranial Stents
    • 8.3.2. Neuroendoscopes
      • 8.3.2.1. Flexible Neuroendoscopes
      • 8.3.2.2. Rigid Neuroendoscopes
    • 8.3.3. Neurosurgical Drills
      • 8.3.3.1. Pneumatic Neurosurgical Drills
      • 8.3.3.2. Electrical Neurosurgical Drills
    • 8.3.4. Radiosurgery Systems
      • 8.3.4.1. Linear Accelerator Radiosurgery Systems
      • 8.3.4.2. Gamma Knife Radiosurgery Systems
    • 8.3.5. Dura Substitutes
      • 8.3.5.1. Biological Dura Substitutes
      • 8.3.5.2. Synthetic Dura Substitutes
    • 8.3.6. Neurosurgical Ablation Devices
      • 8.3.6.1. MRI Guided Focused Ultrasound Systems
      • 8.3.6.2. MRI Guided Laser Therapy Systems
      • 8.3.6.3. MRI Guided RF Ablation Systems
    • 8.3.7. Neurosurgery Instruments
      • 8.3.7.1. Tissue Retractors
      • 8.3.7.2. Forceps
      • 8.3.7.3. Head Frames
      • 8.3.7.4. Cervical Plating systems
      • 8.3.7.5. Perforators
  • 8.4. Market Attractiveness Analysis By Product

9. Global Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032, By End User

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2032
    • 9.3.1. Hospitals
    • 9.3.2. Ambulatory Surgical Centers
    • 9.3.3. Specialized Neurological Institutes
  • 9.4. Market Attractiveness Analysis By End User

10. Global Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032, by Region

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2032
    • 10.3.1. North America
    • 10.3.2. Latin America
    • 10.3.3. Europe
    • 10.3.4. East Asia
    • 10.3.5. South Asia
    • 10.3.6. Oceania
    • 10.3.7. Middle East and Africa (MEA)
  • 10.4. Market Attractiveness Analysis By Region

11. North America Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 11.3.1. By Country
      • 11.3.1.1. U.S.
      • 11.3.1.2. Canada
    • 11.3.2. By Product
    • 11.3.3. By End User
  • 11.4. Market Attractiveness Analysis
    • 11.4.1. By Country
    • 11.4.2. By Product
    • 11.4.3. By End User
  • 11.5. Market Trends
  • 11.6. Key Market Participants - Intensity Mapping
  • 11.7. Drivers and Restraints - Impact Analysis
  • 11.8. Country Level Analysis & Forecast
    • 11.8.1. U.S. Neurosurgery Market
      • 11.8.1.1. Introduction
      • 11.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 11.8.1.2.1. By Product
        • 11.8.1.2.2. By End User
    • 11.8.2. Canada Neurosurgery Market
      • 11.8.2.1. Introduction
      • 11.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 11.8.2.2.1. By Product
        • 11.8.2.2.2. By End User

12. Latin America Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 12.3.1. By Country
      • 12.3.1.1. Brazil
      • 12.3.1.2. Argentina
      • 12.3.1.3. Mexico
      • 12.3.1.4. Rest of Latin America
    • 12.3.2. By Product
    • 12.3.3. By End User
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Product
    • 12.4.3. By End User
  • 12.5. Market Trends
  • 12.6. Key Market Participants - Intensity Mapping
  • 12.7. Drivers and Restraints - Impact Analysis
  • 12.8. Country Level Analysis & Forecast
    • 12.8.1. Brazil Neurosurgery Market
      • 12.8.1.1. Introduction
      • 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.1.2.1. By Product
        • 12.8.1.2.2. By End User
    • 12.8.2. Mexico Neurosurgery Market
      • 12.8.2.1. Introduction
      • 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.2.2.1. By Product
        • 12.8.2.2.2. By End User
    • 12.8.3. Argentina Neurosurgery Market
      • 12.8.3.1. Introduction
      • 12.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.3.2.1. By Product
        • 12.8.3.2.2. By End User

13. Europe Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 13.3.1. By Country
      • 13.3.1.1. Germany
      • 13.3.1.2. France
      • 13.3.1.3. Italy
      • 13.3.1.4. Spain
      • 13.3.1.5. UK
      • 13.3.1.6. BENELUX
      • 13.3.1.7. Russia
      • 13.3.1.8. Nordic Countries
      • 13.3.1.9. Rest of Europe
    • 13.3.2. By Product
    • 13.3.3. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By End User
  • 13.5. Market Trends
  • 13.6. Key Market Participants - Intensity Mapping
  • 13.7. Drivers and Restraints - Impact Analysis
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. Germany Neurosurgery Market
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.1.2.1. By Product
        • 13.8.1.2.2. By End User
    • 13.8.2. Italy Neurosurgery Market
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.2.2.1. By Product
        • 13.8.2.2.2. By End User
    • 13.8.3. France Neurosurgery Market
      • 13.8.3.1. Introduction
      • 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.3.2.1. By Product
        • 13.8.3.2.2. By End User
        • 13.8.3.2.3.
    • 13.8.4. Spain Neurosurgery Market
      • 13.8.4.1. Introduction
      • 13.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.4.2.1. By Product
        • 13.8.4.2.2. By End User
    • 13.8.5. U.K. Neurosurgery Market
      • 13.8.5.1. Introduction
      • 13.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.5.2.1. By Product
        • 13.8.5.2.2. By End User
    • 13.8.6. Benelux Union Neurosurgery Market
      • 13.8.6.1. Introduction
      • 13.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.6.2.1. By Product
        • 13.8.6.2.2. By End User
    • 13.8.7. Nordic Countries Neurosurgery Market
      • 13.8.7.1. Introduction
      • 13.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.7.2.1. By Product
        • 13.8.7.2.2. By End User
    • 13.8.8. Russia Neurosurgery Market
      • 13.8.8.1. Introduction
      • 13.8.8.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.8.2.1. By Product
        • 13.8.8.2.2. By End User

14. South Asia and Pacific Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 14.3.1. By Country
      • 14.3.1.1. India
      • 14.3.1.2. Indonesia
      • 14.3.1.3. Malaysia
      • 14.3.1.4. Thailand
      • 14.3.1.5. Rest of South Asia
    • 14.3.2. By Product
    • 14.3.3. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By End User
  • 14.5. Market Trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. India Neurosurgery Market
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By End User
    • 14.8.2. Indonesia Neurosurgery Market
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By End User
    • 14.8.3. Malaysia Neurosurgery Market
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.3.2.1. By Product
        • 14.8.3.2.2. By End User
    • 14.8.4. Thailand Neurosurgery Market
      • 14.8.4.1. Introduction
      • 14.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.4.2.1. By Product
        • 14.8.4.2.2. By End User

15. East Asia Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 15.3.1. By Country
      • 15.3.1.1. China
      • 15.3.1.2. Japan
      • 15.3.1.3. South Korea
    • 15.3.2. By Product
    • 15.3.3. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By End User
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. China Neurosurgery Market
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By End User
    • 15.8.2. Japan Neurosurgery Market
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By End User
    • 15.8.3. South Korea Neurosurgery Market
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By End User

16. Oceania Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 16.3.1. By Country
      • 16.3.1.1. Australia
      • 16.3.1.2. New Zealand
    • 16.3.2. By Product
    • 16.3.3. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By End User
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. Australia Neurosurgery Market
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By End User
    • 16.8.2. New Zealand Neurosurgery Market
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By End User

17. Middle East and Africa Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 17.3.1. By Country
      • 17.3.1.1. GCC Countries
      • 17.3.1.2. Turkey
      • 17.3.1.3. Israel
      • 17.3.1.4. Northern Africa
      • 17.3.1.5. South Africa
      • 17.3.1.6. Rest of Middle East and Africa
    • 17.3.2. By Product
    • 17.3.3. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By End User
  • 17.5. Market Trends
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. GCC Countries Neurosurgery Market
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By End User
    • 17.8.2. Turkey Neurosurgery Market
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By End User
    • 17.8.3. North Africa Neurosurgery Market
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Product
        • 17.8.3.2.2. By End User
    • 17.8.4. South Africa Neurosurgery Market
      • 17.8.4.1. Introduction
      • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.4.2.1. By Product
        • 17.8.4.2.2. By End User

18. Market Structure Analysis

  • 18.1. Market Analysis by Tier of Companies
  • 18.2. Market Share Analysis of Top Players
  • 18.3. Market Presence Analysis

19. Competition Analysis

  • 19.1. Competition Dashboard
  • 19.2. Competition Benchmarking
  • 19.3. Competition Deep Dive
    • 19.3.1. Stryker Corp.
      • 19.3.1.1. .Overview
      • 19.3.1.2. Product Portfolio
      • 19.3.1.3. Key Financials
      • 19.3.1.4. SWOT Analysis
      • 19.3.1.5. Key Developments
      • 19.3.1.6. Sales Footprint
      • 19.3.1.7. Strategy Overview
        • 19.3.1.7.1. Marketing Strategy
        • 19.3.1.7.2. Product Strategy
        • 19.3.1.7.3. Channel Strategy
    • 19.3.2. B. Braun Melsungen AG
      • 19.3.2.1. Overview
      • 19.3.2.2. Product Portfolio
      • 19.3.2.3. Key Financials
      • 19.3.2.4. SWOT Analysis
      • 19.3.2.5. Key Developments
      • 19.3.2.6. Sales Footprint
      • 19.3.2.7. Strategy Overview
        • 19.3.2.7.1. Marketing Strategy
        • 19.3.2.7.2. Product Strategy
        • 19.3.2.7.3. Channel Strategy
    • 19.3.3. Medtronic plc
      • 19.3.3.1. Overview
      • 19.3.3.2. Product Portfolio
      • 19.3.3.3. Key Financials
      • 19.3.3.4. SWOT Analysis
      • 19.3.3.5. Key Developments
      • 19.3.3.6. Sales Footprint
      • 19.3.3.7. Strategy Overview
        • 19.3.3.7.1. Marketing Strategy
        • 19.3.3.7.2. Product Strategy
        • 19.3.3.7.3. Channel Strategy
    • 19.3.4. DePuy Synthes
      • 19.3.4.1. Overview
      • 19.3.4.2. Product Portfolio
      • 19.3.4.3. Key Financials
      • 19.3.4.4. SWOT Analysis
      • 19.3.4.5. Key Developments
      • 19.3.4.6. Sales Footprint
      • 19.3.4.7. Strategy Overview
        • 19.3.4.7.1. Marketing Strategy
        • 19.3.4.7.2. Product Strategy
        • 19.3.4.7.3. Channel Strategy
    • 19.3.5. Boston Scientific
      • 19.3.5.1. Overview
      • 19.3.5.2. Product Portfolio
      • 19.3.5.3. Key Financials
      • 19.3.5.4. SWOT Analysis
      • 19.3.5.5. Key Developments
      • 19.3.5.6. Sales Footprint
      • 19.3.5.7. Strategy Overview
        • 19.3.5.7.1. Marketing Strategy
        • 19.3.5.7.2. Product Strategy
        • 19.3.5.7.3. Channel Strategy
    • 19.3.6. Terumo Corporation
      • 19.3.6.1. Overview
      • 19.3.6.2. Product Portfolio
      • 19.3.6.3. Key Financials
      • 19.3.6.4. SWOT Analysis
      • 19.3.6.5. Key Developments
      • 19.3.6.6. Sales Footprint
      • 19.3.6.7. Strategy Overview
        • 19.3.6.7.1. Marketing Strategy
        • 19.3.6.7.2. Product Strategy
        • 19.3.6.7.3. Channel Strategy
    • 19.3.7. KARL STORZ GmbH & Co KG
      • 19.3.7.1. Overview
      • 19.3.7.2. Product Portfolio
      • 19.3.7.3. Key Financials
      • 19.3.7.4. SWOT Analysis
      • 19.3.7.5. Key Developments
      • 19.3.7.6. Sales Footprint
      • 19.3.7.7. Strategy Overview
        • 19.3.7.7.1. Marketing Strategy
        • 19.3.7.7.2. Product Strategy
        • 19.3.7.7.3. Channel Strategy
    • 19.3.8. Integra LifeSciences
      • 19.3.8.1. Overview
      • 19.3.8.2. Product Portfolio
      • 19.3.8.3. Key Financials
      • 19.3.8.4. SWOT Analysis
      • 19.3.8.5. Key Developments
      • 19.3.8.6. Sales Footprint
      • 19.3.8.7. Strategy Overview
        • 19.3.8.7.1. Marketing Strategy
        • 19.3.8.7.2. Product Strategy
        • 19.3.8.7.3. Channel Strategy
    • 19.3.9. Penumbra Inc
      • 19.3.9.1. Overview
      • 19.3.9.2. Product Portfolio
      • 19.3.9.3. Key Financials
      • 19.3.9.4. SWOT Analysis
      • 19.3.9.5. Key Developments
      • 19.3.9.6. Sales Footprint
      • 19.3.9.7. Strategy Overview
        • 19.3.9.7.1. Marketing Strategy
        • 19.3.9.7.2. Product Strategy
        • 19.3.9.7.3. Channel Strategy
    • 19.3.10. Adeor Medical AG
      • 19.3.10.1. Overview
      • 19.3.10.2. Product Portfolio
      • 19.3.10.3. Key Financials
      • 19.3.10.4. SWOT Analysis
      • 19.3.10.5. Key Developments
      • 19.3.10.6. Sales Footprint
      • 19.3.10.7. Strategy Overview
        • 19.3.10.7.1. Marketing Strategy
        • 19.3.10.7.2. Product Strategy
        • 19.3.10.7.3. Channel Strategy
    • 19.3.11. Elekta
      • 19.3.11.1. Overview
      • 19.3.11.2. Product Portfolio
      • 19.3.11.3. Key Financials
      • 19.3.11.4. SWOT Analysis
      • 19.3.11.5. Key Developments
      • 19.3.11.6. Sales Footprint
      • 19.3.11.7. Strategy Overview
        • 19.3.11.7.1. Marketing Strategy
        • 19.3.11.7.2. Product Strategy
        • 19.3.11.7.3. Channel Strategy
    • 19.3.12. Clarus Medical
      • 19.3.12.1. Overview
      • 19.3.12.2. Product Portfolio
      • 19.3.12.3. Key Financials
      • 19.3.12.4. SWOT Analysis
      • 19.3.12.5. Key Developments
      • 19.3.12.6. Sales Footprint
      • 19.3.12.7. Strategy Overview
        • 19.3.12.7.1. Marketing Strategy
        • 19.3.12.7.2. Product Strategy
        • 19.3.12.7.3. Channel Strategy
    • 19.3.13. MACHIDA ENDOSCOPE CO., LTD.
      • 19.3.13.1. Overview
      • 19.3.13.2. Product Portfolio
      • 19.3.13.3. Key Financials
      • 19.3.13.4. SWOT Analysis
      • 19.3.13.5. Key Developments
      • 19.3.13.6. Sales Footprint
      • 19.3.13.7. Strategy Overview
        • 19.3.13.7.1. Marketing Strategy
        • 19.3.13.7.2. Product Strategy
        • 19.3.13.7.3. Channel Strategy

20. Assumptions and Acronyms Used

21. Research Methodology